Page 34 - Confidence Interval News Today

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new and updated data across clinical and real-world studies in chronic lymphocytic leukemia (CLL)....

The largest head-to-head trial of PD-1 inhibitors for non-squamous non-small cell lung cancer suggested dostarlimab with chemo aided survival.

OSLO, Norway, Dec. 5, 2022 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces that new...

Taiwan: A recent study published in the Australasian Journal of Dermatology has demonstrated an increased risk of Psoriasis in patients diagnosed with herpes zoster.There are several cases mentioned...

/PRNewswire/ -- BioArctic ABs (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the results from the large global Phase 3 confirmatory...

/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...

TOKYO, Nov 30, 2022 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai's large global Phase 3 confirmatory Clarity AD clinical study of lecanemab (development

Full study results of Eisai’s Phase III Alzheimer's study suggest lecanemab could slow disease progression.

1. In comparison to biomass cookstoves, there was no difference in infant birth weight born to participants who used liquefied petroleum gas (LPG) cookstoves during pregnancy. 2. In comparison to biomass cookstoves, there was also no difference in the incidence of premature birth, premature labor, or stillbirth born to participants who used LPG cookstoves during

Need to figure out the sample you need for an A/B test or how long to run it for? This post will show you how.